Article Details
Retrieved on: 2021-07-01 12:55:49
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
CureVac plans to continue work on its Covid-19 vaccine despite disappointing clinical trial results that showed the shot is just 48% effective.
Article found on: www.cnbc.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here